. Archives of Disease in Childhood, 50, 367. Enteropathogenic Esch. eoli gastroenteritis in premature infants and children treated with fosfomycin. Forty-two infants, some premature, with enteropathogenic Esch. coli (EPEC) gastroenteritis were treated with an oral suspension of fosfomycin in a dose of 100 and 200 mg/kg per day. After the treatment there were 11 secondary clinical infections (6 reinfections and 5 relapses) which received a second treatment with fosfomycin. In total, 53 treatments were made with fosfomycin and in 92% of the cases there was both clinical and bacteriological cure. 93% of the EPEC strains were sensitive to fosfomycin in vitro, their minimum inhibitory concentrations being <64 [±g/ml.
Fosfomycin is a new wide spectrum antibiotic described by Hendlin et al. (1969) and Stapley et al. (1970) . It is very active in vitro against Esch. coli (Zimmerman et al., 1970; Kestle and Kirby, 1970; Martin et al., 1970;  Moreno-Lopez et al., 1971) and has practically no toxicity . The absorption of an oral dose in man is approximately 30 to 40% Mata, 1968-1969;  Foltz, Wallick, and Rosenblum, 1970) . The absence of toxicity and the high acitivity against Esch. coli made us try this new antibiotic on a group of 39 premature babies and infants with gastroenteritis and 3 carriers of enteropathogenic Esch. 
coli (EPEC).
Material and methods Patients. Table I shows the age and sex of the 42 children studied. 90% were less than 3 months old and 40% were premature. 39 of them had diarrhoea with two previous stool cultures positive for EPEC. It is important to emphasize that 76% of the children were infected with EPEC in hospital. The study was made during a hospital epidemic caused by the 0126:K71B16 serotype; for this serotype the proportion of children Received 7 October 1974. infected in hospital was 94%. In 36 children there were other disorders as listed in Table II.  Table III shows the treatments used before fosfomycin. In 32 children (79%) an antibiotic had been used and in 19 of these the treatment lasted more than a week without obtaining any clinical or bacteriological improvement.
Treatment and dosage. The fosfomycin calcium salt was used as a suspension containing 50 mg/ml of active product. It was given orally as the only antibiotic, in doses of 100 or 200 mg/kg per day divided into 3 or 4 units for an average of 7 days.
Bacteriological study. The selection and diagnosis of all the cases were made by stool culture and immunofluorescence. The following culture media were used: MacConkey agar, Selenite broth, SS agar, MRS agar, Mycobiotic agar, and Mannitol-Salt agar. Colony counts were made on fresh specimens of faeces, which were homogenized and then diluted 1/10 to 1/10 000; 0 05 ml of each dilution were plated out on Cysteine-Lactose-Electrolyte-Deficient agar (Oxoid).
The direct immunofluorescence examination was made on the 1/10 dilution of the faeces using polyvalent antisera conjugated to fluorescein isothiocyanate, contrast stained by rhodamine.
EPEC serotyping was done with antisera using the The antibiotic sensitivity of the strains to fosfomycin, other antibiotic and chemotherapeutic agents, was examined by the disc-plate test. The minimum inhibitory concentrations (MIC) of each strain to fosfomycin was determined by the agar dilution method using techniques recommended by WHO (Ericsson and Sherris, 1971 ). An inhibition zone of 10 mm round a 30 ,ug disc was considered to be the minimum reflecting a therapeutic response to the antibiotic. The criteria recommended by the suppliers (Pasteur Institute) were followed for the other antibiotics. Bacteriological examination of the faeces was repeated every 3 days during the course of treatment, 3 days after ending it, and afterwards between the first and fourth weeks.
Fosfomycin determinations. Determinations of fosfomycin in blood and faeces were made using a platediffusion microbiological method with MB-1 159 Erwinia atroseptica as the test organism (H. Wallick and W. Maiese,personal communication, 1969) . Concentrations for the standard curve were 0* 5, 0 75, 1 0, 1 * 5, and 2* 0 ,ug/ml, and dilutions were made in human serum or pH 8* 0 Tris buffer (0 * 05 mol/l) depending upon the assay.
Serum samples were diluted in human serum and stool samples in buffer to approximately 1 0 ,ug/ml. At the working dilutions no stool bacterial interference was seen in the determinations.
Evaluation criteria and secondary infections. We call mild cases those which do not require intravenous fluids and serious cases those needing intravenous drips and frequently having electrolyte disturbances. The criteria of cure were based on the following parameters: the remission of diarrhoea, recovery of lost weight, and elimination of EPEC from faeces. When EPEC were eliminated without clinical response, there was said to be a bacteriological cure. A failure was recorded when there was neither a clinical nor a bacteriological cure. Reinfections were considered to be those cases in which a different serotype or antibiotype of EPEC was 368 method ofthe Pasteur Institute (Le Minor, 1972) . Polyvalent OB and specific OB/O antisera were used; for the latter, the minimum agglutinating values were-1:200 for the 0 titre and 1:1600 for the B titre. Bacteriological studies showed (Table V) that the action of fosfomycin was specific against the causal micro-organism (EPEC) without appreciably altering the rest of the bacterial flora. It is difficult to explain why nonpathogenic Esch. coli were selected during the fosfomycin treatment. The selection of E. cloacae could be based on the frequent resistance of this species to fosfomycin.
Fosfomycin blood andfaecal concentrations. Table  VIIA shows the results of blood levels in two groups of children treated with doses of fosfomycin of 100 and 200 mg/kg per day. Though after the first dose the group of children treated with the smaller dose had an average blood level lower than the second group treated with twice the dose, after a few days of treatment the first group, who were all premature babies, showed levels much higher than those of the second group, no doubt due to the accumulation of fosfomycin due to the physiological renal insufficiency in premature children. In another group of 11 children, treated with 200 mg/kg per day given in 4 doses ( Table VIIB) the concentration of fosfomycin in faeces was determined. It was not intended to study quantitatively elimination through the rectal route, but to determine the active antibiotic concentration.
Clinical results. 46, 47, 36, In no case did we find any increase in the values of transaminase, urea, creatinine, and alkaline phosphatase.
Discussion
The treatment of intestinal bacterial infections with antibiotics was questioned by Dixon (1965) and Aserkoff and Bennett (1969) , who noted a longer period of excretion of the pathogenic flora in the treated patients than in nontreated ones. Technical progress in fluid replacement and in the general care of the childwith diarrhoea have considerably improved the prognosis of these patients, but we believe that antibiotic therapy can improve it further, especially in the acute phase of the disease. In the intestinal invasive growth phase of EPEC, antibiotics can probably reduce the pathogenic EPEC population and so the total amount of enterotoxin produced, decreasing the pathophysiological effects of this substance. Also, as the pathogenic EPEC population is reduced in the baby, antibiotic therapy could help prevent acute epidemic dissemination, which is very important in children's hospitals.
It is possible that the wide spectrum antibiotics, especially high doses, cause suppression of the normal antagonist flora permitting a possible superinfection, relapse, or reinfection. The possibility of affecting the normal antagonist flora is probably more important in the subacute or chronic phase of the disease corresponding to the spontaneous resettlement of this flora. This could explain the negative effect of the prolonged antibiotherapy in the proportion of carriers of enteropathogenic organisms after the acute bacterial diarrhoea. Haltalin, Nelson, and Kusmiesz (1973) 
